Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO
Related links
Similars in
SciELO
Share
Permalink
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Print version ISSN 2225-5109On-line version ISSN 2227-4731
Abstract
PAZ-IBARRA, José Luis; SIURA-TREVEJO, Gerson; URQUIZA-SALVADOR, Diana and SOMOCURCIO-PERALTA, José. Parathyroid carcinoma in a patient with tertiary hyperparathyroidism. Rev. Cuerpo Med. HNAAA [online]. 2022, vol.15, n.2, pp.284-287. Epub June 10, 2022. ISSN 2225-5109. http://dx.doi.org/10.35434/rcmhnaaa.2022.152.1224.
Background:
Most patients with terminal chronic kidney disease on hemodialysis develop secondary hyperparathyroidism. Sometimes this type of secondary hyperparathyroidism becomes severe and refractory to medical treatment, some will even develop tertiary hyperparathyroidism, the treatment of both situations is usually subtotal or total parathyroidectomy.
Case Report:
We present the case of a 29-year-old patient with end-stage kidney disease on hemodialysis for 13 years, who developed tertiary hyperparathyroidism, for which he underwent subtotal parathyroidectomy with half gland autotransplantation; the pathological study reported the presence of a parathyroid carcinoma in one of the four excised parathyroid glands.
Conclusion:
Parathyroid carcinoma is a rare neoplasm that causes primary hyperparathyroidism in less than 1% of all cases, and has been reported in some patients operated on for the development of tertiary hyperparathyroidism.
Keywords : Hyperparathyroidism, Tertiary hyperparathyroidism; Parathyroid carcinoma; End-stage chronic kidney disease; Hemodialysis.
